{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:01:12Z","timestamp":1793880072167,"version":"4.7.0"},"reference-count":127,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3748\/wjg.v22.i4.1411","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T03:31:43Z","timestamp":1453692703000},"page":"1411","source":"Crossref","is-referenced-by-count":51,"title":["Alcoholic liver disease and hepatitis C virus infection"],"prefix":"10.3748","volume":"22","author":[{"given":"Ignacio","family":"Novo-Veleiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Caldwell SH, Jeffers LJ, Ditomaso A, Millar A, Clark RM, Rabassa A, Reddy KR, De Medina M, Schiff ER. Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors. Am J Gastroenterol 1991;86:1219-1223."},{"key":"ref2","unstructured":"Esteban JI, Esteban R, Viladomiu L, L&oacute;pez-Talavera JC, Gonz&aacute;lez A, Hern&aacute;ndez JM, Roget M, Vargas V, Genesc&agrave; J, Buti M. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989;2:294-297."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270637"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Bode JC, Biermann J, Kohse KP, Walker S, Bode C. High incidence of antibodies to hepatitis C virus in alcoholic cirrhosis: fact or fiction? Alcohol Alcohol 1991;26:111-114.","DOI":"10.1093\/oxfordjournals.alcalc.a045089"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Nalpas B, Thiers V, Pol S, Driss F, Thepot V, Berthelot P, Brechot C. Hepatitis C viremia and anti-HCV antibodies in alcoholics. J Hepatol 1992;14:381-384.","DOI":"10.1016\/0168-8278(92)90187-T"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Befrits R, Hedman M, Blomquist L, Allander T, Grillner L, Kinnman N, Rubio C, Hultcrantz R. Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease. Scand J Gastroenterol 1995;30:1113-1118.","DOI":"10.3109\/00365529509101616"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Galperim B, Cheinquer H, Stein A, Fonseca A, Lunge V, Ikuta N. Prevalence of hepatitis C virus in alcoholic patients: role of parenteral risk factors. Arq Gastroenterol 2006;43:81-84.","DOI":"10.1590\/S0004-28032006000200004"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agt044"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Bruguera M, Forns X. [Hepatitis C in Spain]. Med Clin (Barc) 2006;127:113-117.","DOI":"10.1157\/13090276"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-10-200605160-00004"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2015.14093"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Hutchinson SJ, Bird SM, Goldberg DJ. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol 2005;3:1150-1159.","DOI":"10.1016\/S1542-3565(05)00407-6"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260308"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31827afb3a"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2006.00304.x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Henry JA, Moloney C, Rivas C, Goldin RD. Increase in alcohol related deaths: is hepatitis C a factor? J Clin Pathol 2002;55:704-707.","DOI":"10.1136\/jcp.55.9.704"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.07.027"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36780"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280330"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01948.x"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270404"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Khan MH, Thomas L, Byth K, Kench J, Weltman M, George J, Liddle C, Farrell GC. How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C? J Gastroenterol Hepatol 1998;13:419-426.","DOI":"10.1111\/j.1440-1746.1998.tb00657.x"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2007.00377.x"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.11.016"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2006.00083.x"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2006.00837.x"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04591.x"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Duguay L, Coutu D, Hetu C, Joly JG. Inhibition of liver regeneration by chronic alcohol administration. Gut 1982;23:8-13.","DOI":"10.1136\/gut.23.1.8"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Otani K, Korenaga M, Beard MR, Li K, Qian T, Showalter LA, Singh AK, Wang T, Weinman SA. Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 2005;128:96-107.","DOI":"10.1053\/j.gastro.2004.10.045"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Perlemuter G, Lett&eacute;ron P, Carnot F, Zavala F, Pessayre D, Nalpas B, Br&eacute;chot C. Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model. J Hepatol 2003;39:1020-1027.","DOI":"10.1016\/S0168-8278(03)00414-8"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26618"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50295"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i11.1337"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.056697"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26010"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12005"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2014.02.002"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.145870"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2011.01544.x"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Takahashi K, Takahashi T, Takahashi S, Watanabe K, Boku S, Matsui S, Arai F, Asakura H. Difference in quasispecies of the hypervariable region 1 of hepatitis C virus between alcoholic and non-alcoholic patients. J Gastroenterol Hepatol 2001;16:416-423.","DOI":"10.1046\/j.1440-1746.2001.02462.x"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300131"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00587.x"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.059873"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.12.005"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2007.02.007"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Kohgo Y, Ohtake T, Ikuta K, Suzuki Y, Hosoki Y, Saito H, Kato J. Iron accumulation in alcoholic liver diseases. Alcohol Clin Exp Res 2005;29:189S-193S.","DOI":"10.1097\/01.alc.0000189274.00479.62"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2005.00662.x"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Purohit V, Russo D, Salin M. Role of iron in alcoholic liver disease: introduction and summary of the symposium. Alcohol 2003;30:93-97.","DOI":"10.1016\/S0741-8329(03)00132-0"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301239"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1297926"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000237"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181c10477"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12890"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.476"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26767"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.01.025"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24283"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i41.6969"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.064501"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1003585107"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23290"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2008.0805"},{"key":"ref63","unstructured":"Abd El-Moneim E, Younis FA, Allam N, Gameel K, Osman M. Gene deletion of glutathione S-transferase M1 and T1 and risk factors of hepatocellular carcinoma in Egyptian patients. Egypt J Immunol 2008;15:125-134."},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04862.x"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2014.12.011"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agn026"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i16.2449"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.11.003"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Jeng JE, Tsai JF, Chuang LY, Ho MS, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML. Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia 2007;9:987-992.","DOI":"10.1593\/neo.07781"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.011.10258"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2012.05.010"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Ho SY, Wang YJ, Chen HL, Chen CH, Chang CJ, Wang PJ, Chen HH, Guo HR. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 2004;15:657-663.","DOI":"10.1023\/B:CACO.0000036173.99930.75"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwp236"},{"key":"ref74","unstructured":"World Health Organization. Hepatitis C. (accessed Jul 9, 2014). Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/csr\/disease\/hepatitis\/whocdscsrlyo2003\/en\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.who.int\/csr\/disease\/hepatitis\/whocdscsrlyo2003\/en\/<\/ext-link>."},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"De Silva HJ, Vitarana T, Ratnatunga N, Breschkin A, Withane N, Kularatne WN. Prevalence of hepatitis C virus markers in Sri Lankan patients with alcoholic cirrhosis. J Gastroenterol Hepatol 1994;9:381-384.","DOI":"10.1111\/j.1440-1746.1994.tb01259.x"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Rosman AS, Paronetto F, Galvin K, Williams RJ, Lieber CS. Hepatitis C virus antibody in alcoholic patients. Association with the presence of portal and\/or lobular hepatitis. Arch Intern Med 1993;153:965-969.","DOI":"10.1001\/archinte.1993.00410080031005"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Par&eacute;s A, Barrera JM, Caballer&iacute;a J, Ercilla G, Bruguera M, Caballer&iacute;a L, Castillo R, Rod&eacute;s J. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 1990;12:1295-1299.","DOI":"10.1002\/hep.1840120608"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Nagata S, Ishii H, Yokoyama H, Kato S, Moriya S, Maruyama K, Takahashi H, Tsuchiya M. Influence of HCV infection and its subtypes on clinical course of alcoholic liver disease. Gastroenterol Jpn 1993;28 Suppl 5:91-94.","DOI":"10.1007\/BF02989215"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Coelho-Little ME, Jeffers LJ, Bernstein DE, Goodman JJ, Reddy KR, de Medina M, Li X, Hill M, La Rue S, Schiff ER. Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease. Alcohol Clin Exp Res 1995;19:1173-1176.","DOI":"10.1111\/j.1530-0277.1995.tb01597.x"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e3182a50817"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0095"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Brillanti S, Masci C, Siringo S, Di Febo G, Miglioli M, Barbara L. Serological and histological aspects of hepatitis C virus infection in alcoholic patients. J Hepatol 1991;13:347-350.","DOI":"10.1016\/0168-8278(91)90079-Q"},{"key":"ref83","unstructured":"Saigal S, Kapoor D, Tandon N, Thakur V, Guptan RC, Agarwal SR, Sarin SK. High seroprevalence and clinical significance of hepatitis B and C infection in hospitalized patients with alcoholic cirrhosis. J Assoc Physicians India 2002;50:1002-1006."},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Sata M, Fukuizumi K, Uchimura Y, Nakano H, Ishii K, Kumashiro R, Mizokami M, Lau JY, Tanikawa K. Hepatitis C virus infection in patients with clinically diagnosed alcoholic liver diseases. J Viral Hepat 1996;3:143-148.","DOI":"10.1111\/j.1365-2893.1996.tb00005.x"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Kwon SY, Ahn MS, Chang HJ. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea. J Gastroenterol Hepatol 2000;15:1282-1286.","DOI":"10.1046\/j.1440-1746.2000.2336.x"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Verbaan H, Andersson K, Eriksson S. Intravenous drug abuse--the major route of hepatitis C virus transmission among alcohol-dependent individuals? Scand J Gastroenterol 1993;28:714-718.","DOI":"10.3109\/00365529309098279"},{"key":"ref87","unstructured":"Gonz&aacute;lez Quintela A, Alende R, Aguilera A, Tom&eacute; S, Gude F, P&eacute;rez Becerra E, Torre A, Mart&iacute;nez V&aacute;zquez JM, Barrio E. [Hepatitis C virus antibodies in alcoholic patients]. Rev Clin Esp 1995;195:367-372."},{"key":"ref88","unstructured":"Jiang JJ, Dubois F, Driss F, Carnot F, Thepot V, Pol S, Berthelot P, Brechot C, Nalpas B. Clinical impact of drug addiction in alcoholics. Alcohol Alcohol 1995;30:55-60."},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.04.004"},{"key":"ref90","unstructured":"Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, Jewett A, Baack B, Rein DB, Patel N. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012;61:1-32."},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.05.001"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22576"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i8.966"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306218"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.11.018"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.02.051"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214854"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214853"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316145"},{"key":"ref100","unstructured":"American Association for the Study of Liver Diseases. Recommendations for testing, Managing, and Treating Hepatitis C. (accessed Dec 4, 2015). Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hcvguidelines.org\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.hcvguidelines.org\/<\/ext-link>."},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402454"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316366"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27705"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.05.021"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.02.016"},{"key":"ref106","doi-asserted-by":"crossref","unstructured":"Okazaki T, Yoshihara H, Suzuki K, Yamada Y, Tsujimura T, Kawano K, Yamada Y, Abe H. Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers. Scand J Gastroenterol 1994;29:1039-1043.","DOI":"10.3109\/00365529409094883"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.02.023"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009482"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010494"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit274"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014463"},{"key":"ref112","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed Arlington: American Psychiatric Publishing; 2013;.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0043-4"},{"key":"ref114","doi-asserted-by":"crossref","unstructured":"Bohn MJ, Babor TF, Kranzler HR. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol 1995;56:423-432.","DOI":"10.15288\/jsa.1995.56.423"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu097"},{"key":"ref116","unstructured":"World Health Organization. Guidelines for the screening, care and treatment of persons with hepatitis C infection. (accessed Jul 21, 2014). Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/hepatitis\/hepatitis-c-guidelines\/en\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.who.int\/hiv\/pub\/hepatitis\/hepatitis-c-guidelines\/en\/<\/ext-link>."},{"key":"ref117","unstructured":"World Health Organization. The ASSIST project - Alcohol, Smoking and Substance Involvement Screening Test. (accessed 2014 Jul 21). Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/substance_abuse\/activities\/assist\/en\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.who.int\/substance_abuse\/activities\/assist\/en\/<\/ext-link>."},{"key":"ref118","unstructured":"World Health Organization. The ASSIST-linked brief intervention for hazardous and harmful substance use. (accessed Aug 18, 2014). Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/substance_abuse\/publications\/en\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.who.int\/substance_abuse\/publications\/en\/<\/ext-link>."},{"key":"ref119","unstructured":"National Institute on Alcohol Abuse and Alcoholism. Helping patients who drink too much. A clinician&rsquo;s guideline. (accessed Aug 18, 2014). Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/pubs.niaaa.nih.gov\/publications\/Practitioner\/CliniciansGuide2005\/clinicians_guide.htm\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/pubs.niaaa.nih.gov\/publications\/Practitioner\/CliniciansGuide2005\/clinicians_guide.htm<\/ext-link>."},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3628"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2007.00593.x"},{"key":"ref122","doi-asserted-by":"crossref","unstructured":"Forns X, Caballer&iacute;a J, Bruguera M, Salmer&oacute;n JM, Vilella A, Mas A, Par&eacute;s A, Rod&eacute;s J. Disulfiram-induced hepatitis. Report of four cases and review of the literature. J Hepatol 1994;21:853-857.","DOI":"10.1016\/S0168-8278(94)80249-1"},{"key":"ref123","doi-asserted-by":"crossref","unstructured":"Atkinson RL, Berke LK, Drake CR, Bibbs ML, Williams FL, Kaiser DL. Effects of long-term therapy with naltrexone on body weight in obesity. Clin Pharmacol Ther 1985;38:419-422.","DOI":"10.1038\/clpt.1985.197"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp140028"},{"key":"ref125","doi-asserted-by":"crossref","unstructured":"Mozayani A, Carter J, Nix R. Distribution of topiramate in a medical examiner&rsquo;s case. J Anal Toxicol 1999;23:556-558.","DOI":"10.1093\/jat\/23.6.556"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agr017"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2011.12.010"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i4\/1411.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T23:18:20Z","timestamp":1718320700000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i4\/1411.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v22.i4.1411","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}